Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Efficacy of Efimosfermin Alfa in Participants With Biopsy-Confirmed F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-1)

Singapore, July 8 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and ... और पढ़ें

Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Tolerability of Efimosfermin Alfa in Participants With Known or Suspected F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-2)

Singapore, July 8 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and ... और पढ़ें

Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending Dose and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LY4302814 in Healthy Participants

Singapore, July 8 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending D... और पढ़ें

Singapore Clinical Trial: A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined with Chemotherapy Versus Investigator’s Choice of TKI Combined with Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Singapore, July 8 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combine... और पढ़ें

Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, July 8 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the pos... और पढ़ें

Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, July 8 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507)... और पढ़ें

NBFCs credit growth accelerates to 14.2% in May 2026

Mumbai, July 8 -- RBI released data on sectoral deployment of credit by non-banking financial companies (NBFCs) for the month of May 2026, collected from major NBFCs and housing finance companies (HFC... और पढ़ें

Clinical Trial: Preoperative Performance Indicators, Preoxygenation and Oxygen Reserve Relationship

U.S., July 8 -- ClinicalTrials.gov registry received information related to the study (NCT07688941) titled 'Preoperative Performance Indicators, Preoxygenation and Oxygen Reserve Relationship' on June... और पढ़ें

Clinical Trial: AI Virtual Patient Training for Dental Student History Taking

U.S., July 8 -- ClinicalTrials.gov registry received information related to the study (NCT07688668) titled 'AI Virtual Patient Training for Dental Student History Taking' on June 30. Brief Summary: T... और पढ़ें

Clinical Trial: Evaluation of Mosquito Repellent Products' Efficacy, Safety, and Public Health Implications

U.S., July 8 -- ClinicalTrials.gov registry received information related to the study (NCT07686159) titled 'Evaluation of Mosquito Repellent Products' Efficacy, Safety, and Public Health Implications'... और पढ़ें

• ««
• «
• 299
• 300
• 301
• 302
• 303
• 304
• 305
• 306
• 307
• 308
• »
• »»